EFFECT OF EXERCISE TRAINING ON PLATELET AGGREGATION AND ON P2Y12 INHIBITOR RESISTANCE AFTER MYOCARDIAL INFARCTION: A RANDOMIZED CLINICAL TRIAL

被引：0
|
作者：
Dalcoquio, Talia
de Mendonca Furtado, Remo Holanda
Britto Britto Arantes, Flavia Bittar
dos Santos, Mayara Alves
Alves, Leandro Silva
Pinto Brandao Rondon, Maria Urbana
Ferreira-Santos, Larissa
de Nazare Nunes Alves, Maria Janieire
Ferrari, Aline Gehlen
Genestreti, Paulo Rizzo
Baracioli, Luciano Moreira
Franci, Andre
Salsoso, Rocio
Negrao, Carlos Eduardo
Nicolau, Jose Carlos
机构：
[1] Univ Sao Paulo, Hosp Clin, Fac Med, Inst Coracao InCor, Sao Paulo, Brazil
[2] Univ Fed Uberlandia, Uberlandia, MG, Brazil
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1116-130
引用
收藏
页码：1618 / 1618
页数：1
相关论文
共 50 条
  • [41] Glycoprotein IIb/IIIa and P2Y12 Induction by Oligochitosan Accelerates Platelet Aggregation
    Periayah, Mercy Halleluyah
    Halim, Ahmad Sukari
    Yaacob, Nik Soriani
    Saad, Arman Zaharil Mat
    Hussein, Abdul Rahim
    Rashid, Ahmad Hazri Abdul
    Ujang, Zanariah
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [42] Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes
    Diehl, Philipp
    Olivier, Christoph
    Halscheid, Christoph
    Helbing, Thomas
    Bode, Christoph
    Moser, Martin
    BASIC RESEARCH IN CARDIOLOGY, 2010, 105 (03) : 379 - 387
  • [43] Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes
    Philipp Diehl
    Christoph Olivier
    Christoph Halscheid
    Thomas Helbing
    Christoph Bode
    Martin Moser
    Basic Research in Cardiology, 2010, 105 : 379 - 387
  • [44] P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention
    Zhou, Xuan
    Angiolillo, Dominick J.
    Ortega-Paz, Luis
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (10)
  • [45] Platelet P2Y12 Receptor InhibitionAn Update on Clinical Drug Development
    David Vivas
    Dominick J. Angiolillo
    American Journal of Cardiovascular Drugs, 2010, 10 : 217 - 226
  • [46] PLATELET P2Y12 INHIBITOR USE AND RISK OF COLORECTAL CANCER AND RELATED DEATH
    Fuchs, Michael
    Ha, Jane
    Yan, Jane
    Bottai, Matteo
    Song, Mingyang
    Simon, Tracey G.
    Ye, Weimin
    Chan, Andrew T.
    Ludvigsson, Jonas F.
    GASTROENTEROLOGY, 2024, 166 (05) : S268 - S269
  • [47] Platelet P2Y12 Receptor Inhibition An Update on Clinical Drug Development
    Vivas, David
    Angiolillo, Dominick J.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (04) : 217 - 226
  • [48] Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial
    Tavenier, Anne H.
    Hermanides, Renicus S.
    Ottervanger, Jan Paul.
    Belitser, Svetlana V.
    Klungel, Olaf. H.
    van't Hof, Arnoud W. J.
    AMERICAN HEART JOURNAL, 2022, 243 : 39 - 42
  • [49] The Use Pattern and Clinical Impact of Novel P2Y12 Receptor Antagonists for Acute Myocardial Infarction in Korea
    Kim, Soo-Joong
    KOREAN CIRCULATION JOURNAL, 2017, 47 (06) : 864 - 867
  • [50] Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitors
    Thomas, Mark R.
    Storey, Robert F.
    VASCULAR PHARMACOLOGY, 2016, 84 : 25 - 27
12345